Clinical relevance of HRD score in pheochromocytomas and paragangliomas: molecular cluster distribution and prognostic implications

医学 临床意义 内科学 肿瘤科 分布(数学) 星团(航天器) 替莫唑胺 转移性黑色素瘤 嗜铬细胞瘤 相关性(法律)
作者
Yue Zhou,Yunying Cui,W Q Zhang,Tianyi Li,Amy Y. Tong
出处
期刊:Endocrine-related Cancer [Bioscientifica]
卷期号:33 (4)
标识
DOI:10.1530/erc-25-0301
摘要

Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors with variable metastatic potential across molecular clusters. While the homologous recombination deficiency (HRD) score has been established as a surrogate for HRD-related genomic instability to guide prognostic evaluation and therapeutic options in multiple solid tumors, its relevance in PPGLs remains unexplored. Here, data from 133 PPGL patients in the TCGA database were extracted to assess relationships between the HRD score and molecular clusters, metastasis, metastasis-free survival (MFS), and other clinical characteristics. Subsequently, a real-world cohort of 54 matched blood-tumor pairs was subjected to whole-exome sequencing, with HRD scores calculated to confirm the prior observations. The median HRD score was 7.0 and 9.0 in the TCGA-PPGL dataset and the clinical cohort, respectively. In the TCGA dataset, an elevated HRD score significantly correlated with metanephrine secretion, C2 cluster, and metastasis. Multivariate analysis identified a higher HRD score as an independent risk factor for shorter MFS (HR = 1.33, P = 0.008). Patients with HRD scores ≥ 7 exhibited significantly shorter MFS (P = 0.037), which was observed exclusively within the C1A cluster (P = 0.007). Analyses of our clinical validation cohort corroborated this cluster-specific distribution and further revealed higher HRD scores in three temozolomide-treated PPGLs compared with those treatment-naive C1A tumors (P = 0.043). In conclusion, despite exhibiting lower levels in C1A clusters, an elevated HRD score emerges as a promising indicator for refined metastatic risk stratification in PPGLs. Futhermore, the substantial increase in HRD score following temozolomide treatment provides a rationale for PARP inhibitor sequential or combination therapy in metastatic PPGLs.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
lulu完成签到 ,获得积分10
1秒前
yyy完成签到,获得积分10
1秒前
再吃一颗苹果完成签到,获得积分10
2秒前
如意听安发布了新的文献求助10
2秒前
null发布了新的文献求助10
2秒前
3秒前
Iris完成签到,获得积分20
3秒前
一柯完成签到,获得积分20
4秒前
4秒前
沉静的清涟完成签到,获得积分10
4秒前
科研通AI6.4的应助被想喝奶茶采纳,获得10
5秒前
Orange的应助被科研通管家采纳,获得10
5秒前
勤奋一一的应助被科研通管家采纳,获得10
5秒前
田様的应助被科研通管家采纳,获得10
5秒前
zhonglv7的应助被科研通管家采纳,获得10
5秒前
CodeCraft的应助被科研通管家采纳,获得10
5秒前
所所的应助被七安采纳,获得10
5秒前
无花果的应助被科研通管家采纳,获得10
5秒前
星辰大海的应助被科研通管家采纳,获得10
5秒前
充电宝的应助被愉快数据线采纳,获得10
5秒前
研友_VZG7GZ的应助被科研通管家采纳,获得10
6秒前
白糖发布了新的文献求助10
6秒前
脑洞疼的应助被科研通管家采纳,获得10
6秒前
lizzie发布了新的文献求助10
6秒前
皮卡丘发布了新的文献求助30
6秒前
作业本的应助被科研通管家采纳,获得10
6秒前
爆米花的应助被科研通管家采纳,获得10
6秒前
星辰大海的应助被科研通管家采纳,获得10
6秒前
6秒前
田様的应助被科研通管家采纳,获得10
6秒前
Lucas的应助被科研通管家采纳,获得10
7秒前
思源的应助被科研通管家采纳,获得10
7秒前
烂漫的从彤完成签到,获得积分10
7秒前
所所的应助被科研通管家采纳,获得10
7秒前
李远锐完成签到 ,获得积分10
7秒前
CipherSage的应助被科研通管家采纳,获得10
7秒前
小蘑菇的应助被科研通管家采纳,获得10
7秒前
7秒前
8秒前
糜厉完成签到,获得积分10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8182102
求助须知:如何正确求助?哪些是违规求助? 9571775
关于积分的说明 21819723
捐赠科研通 7778500
什么是DOI,文献DOI怎么找? 3433617
关于科研通互助平台的介绍 2557786
邀请新用户注册赠送积分活动 2479651